tirzepatide common side effects Dosing Semaglutide vs Tirzepatide, which is

High-Risk Groups: Who Needs Extra Caution

GI amplification and class-level risks explained.

AstraZeneca - Building a strong obesity and metabolic disease pipeline Amgen - MariTide showing promising obesity treatment potential Roche - Expanding through strategic acquisitions and obesity-focused programs Pfizer - Continuing development efforts in oral obesity medicines Structure Therapeutics - Advancing next-generation oral GLP-1 candidates Viking Therapeutics - Emerging as a major obesity treatment contender Altimmune - Developing innovative metabolic disease therapies Boehringer Ingelheim - Investing in future cardiometabolic opportunities Why is everyone chasing GLP-1

Learn what the GLP-1 hormone is, how it works, and why it affects hunger, fullness, and blood sugar

But this takes the cake.

Here's what to know.